Topic Highlight
Copyright ©2014 Baishideng Publishing Group Inc.
World J Gastrointest Pathophysiol. Nov 15, 2014; 5(4): 462-466
Published online Nov 15, 2014. doi: 10.4291/wjgp.v5.i4.462
Table 2 Quality of care indicators in inflammatory bowel disease
Quality of care indicators
10 quality of care indicators byIBD: type, anatomic location and activity all assessed
American Gastroenterology AssociationIBD preventive care: corticosteroid sparing therapy
IBD preventive care: corticosteroid related iatrogenic injury - bone loss assessment
IBD preventive care: influenza immunization
IBD preventive care: pneumococcal immunization
Testing for latent tuberculosis before initiating anti-TNF therapy
Assessment of hepatitis B virus before initiating anti-TNF therapy
Testing for Clostridium difficile - inpatient measure
Prophylaxis for venous thromboembolism - inpatient measure
IBD preventive care: tobacco user - screening and cessation intervention
CCFA top 10 quality outcome indicators of IBDCorticosteroid use
Proportion of patients with steroid-free clinical remission for a 12-mo period
Proportion of patients currently taking prednisone
Number of days per month and year lost from school or work because of IBD
Number of days hospitalized per year because of IBD
Number of emergency room visits per year for IBD
Proportion of patients with malnutrition
Proportion of patients with anemia
Proportion of patients with normal disease-targeted health-related quality of life
Proportion of patients currently taking narcotic analgesics
Proportion of patients with nighttime bowel movements or leakage
Proportion of patients with incontinence in the past month